Fengxiang Huang

531 total citations
24 papers, 367 citations indexed

About

Fengxiang Huang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Fengxiang Huang has authored 24 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Fengxiang Huang's work include Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Fengxiang Huang is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers) and Retinoids in leukemia and cellular processes (2 papers). Fengxiang Huang collaborates with scholars based in China, Japan and Canada. Fengxiang Huang's co-authors include Juan Wang, Lijun Miao, Jiacai Wu, Xu Chen, Ruixia Zhang, Hongjie Chen, Qiang Peng, Kai Ma, Jing Wang and Ya‐Hui Huang and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Frontiers in Physiology.

In The Last Decade

Fengxiang Huang

22 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengxiang Huang China 9 187 117 74 55 49 24 367
Mosang Yu China 11 193 1.0× 87 0.7× 106 1.4× 55 1.0× 25 0.5× 22 422
Zimam Mahmud Bangladesh 12 199 1.1× 58 0.5× 66 0.9× 24 0.4× 82 1.7× 38 420
Yuhao Teng China 9 198 1.1× 79 0.7× 34 0.5× 43 0.8× 54 1.1× 19 340
Hongping Wang China 13 251 1.3× 106 0.9× 49 0.7× 37 0.7× 51 1.0× 43 517
Xiao-bin Cheng China 12 271 1.4× 62 0.5× 49 0.7× 65 1.2× 113 2.3× 27 494
Rut Klinger Ireland 8 263 1.4× 92 0.8× 94 1.3× 33 0.6× 103 2.1× 14 502
Guangdong Tong China 14 219 1.2× 75 0.6× 164 2.2× 43 0.8× 25 0.5× 48 463
Yuewei Wang China 11 188 1.0× 86 0.7× 40 0.5× 132 2.4× 45 0.9× 42 389
Tibor Bielik Slovakia 9 181 1.0× 102 0.9× 28 0.4× 22 0.4× 61 1.2× 10 343

Countries citing papers authored by Fengxiang Huang

Since Specialization
Citations

This map shows the geographic impact of Fengxiang Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxiang Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxiang Huang more than expected).

Fields of papers citing papers by Fengxiang Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengxiang Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxiang Huang. The network helps show where Fengxiang Huang may publish in the future.

Co-authorship network of co-authors of Fengxiang Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengxiang Huang. A scholar is included among the top collaborators of Fengxiang Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxiang Huang. Fengxiang Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Fengxiang, Yu Wang, Apar Kishor Ganti, et al.. (2025). Prognostic analysis and development of a predictive model for pulmonary invasive mucinous adenocarcinoma. Journal of Thoracic Disease. 17(7). 5146–5163.
3.
Wang, Qilong, Nannan Sun, Jianhao Li, Fengxiang Huang, & Zhao Zhang. (2024). Liquid-Liquid Phase Separation in the Prognosis of Lung Adenocarcinoma: An Integrated Analysis. Current Cancer Drug Targets. 25(4). 323–334. 1 indexed citations
5.
Huang, Fengxiang, et al.. (2023). Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Clinical & Translational Oncology. 26(2). 468–476. 4 indexed citations
6.
Huang, Fengxiang, et al.. (2023). Diagnostic accuracy and microbial profiles of tuberculous pleurisy: a comparative study of metagenomic next generation sequencing and GeneXpert Mycobacterium tuberculosis. Frontiers in Cellular and Infection Microbiology. 13. 1243441–1243441. 3 indexed citations
7.
Ma, Kai, Fengxiang Huang, Yin Wang, et al.. (2022). Relationship between tumor mutational burden, gene mutation status, and clinical characteristics in 340 cases of lung adenocarcinoma. Cancer Medicine. 11(22). 4389–4397. 2 indexed citations
11.
Wang, Juan, Jiangang Jia, Luwei Zhou, et al.. (2022). A Combined Transcriptomic and Proteomic Approach to Reveal the Effect of Mogroside V on OVA-Induced Pulmonary Inflammation in Mice. Frontiers in Immunology. 13. 800143–800143. 22 indexed citations
12.
Huang, Fengxiang, Jiaqi Tang, Qilong Wang, et al.. (2022). Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report. Translational Cancer Research. 11(9). 3337–3342. 6 indexed citations
13.
Ma, Kai, et al.. (2022). Pathogenesis of sarcopenia in chronic obstructive pulmonary disease. Frontiers in Physiology. 13. 850964–850964. 33 indexed citations
14.
Chen, Hongjie, Lijun Miao, Fengxiang Huang, et al.. (2020). Glochidiol, a natural triterpenoid, exerts its anti-cancer effects by targeting the colchicine binding site of tubulin. Investigational New Drugs. 39(2). 578–586. 4 indexed citations
15.
Liu, Ying, Fengxiang Huang, Hongjie Chen, et al.. (2020). Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.. PubMed. 45(9). 1044–1052. 5 indexed citations
16.
Li, Zhi, Bo You, Liang Ding, Haibo Gao, & Fengxiang Huang. (2019). Trajectory Tracking Control for WMRs with the Time-Varying Longitudinal Slippage Based on a New Adaptive SMC Method. International Journal of Aerospace Engineering. 2019. 1–13. 5 indexed citations
17.
Huang, Fengxiang, Hongjie Chen, Qiang Peng, et al.. (2018). LncRNA BLACAT1 is involved in chemoresistance of non‑small cell lung cancer cells by regulating autophagy. International Journal of Oncology. 54(1). 339–347. 73 indexed citations
18.
Huang, Fengxiang, et al.. (2015). Erythromycin enhances the anti-inflammatory activity of budesonide in COPD rat model.. PubMed. 8(12). 22217–26. 8 indexed citations
19.
Wang, Juan, et al.. (2015). Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK Pathway. International Journal of Molecular Sciences. 16(8). 19851–19867. 71 indexed citations
20.
Miao, Lijun, et al.. (2014). Stat3 inhibits Beclin 1 expression through recruitment of HDAC3 in nonsmall cell lung cancer cells. Tumor Biology. 35(7). 7097–7103. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026